Navigation Links
Ettan DIGE Imager


The Ettan™ DIGE Imager (Fig 1) is a scanning CCD camera designed for applications in the life sciences. In particular, it has been engineered to create high quality images of 2-D DIGE gels. By combining high resolution with precise motion control, the Ettan DIGE Imager produces accurate multichannel images of your Cy™2-, Cy3-, and Cy5-labeled gel. The system has also been designed to image a wide range of other fluorescent gel applications, and can be used with the new ECL Plex™ Western Blotting System.

The imager is controlled from the Ettan DIGE Imager software, and can be set up for a variety of gel formats. Results from the Ettan DIGE Imager are directly compatible with ImageQuant™ TL, ImageMaster™ 2D Platinum, and DeCyder™ 2-D Differential Analysis (DeCyder 2-D) Software.

ImageMaster 2D Platinum v6.0 comes in two flavors: DIGE and non-DIGE. The newly developed DIGE-enabled version of the software comprises powerful and versatile tools for the analysis of images from DIGE experiments. Together with the Ettan DIGE Imager, ImageMaster 2D Platinum v6.0, DeCyder 2-D v6.5, and DeCyder Extended Data Analysis (EDA) Software create a powerful platform of image capture and analysis tools that offers flexibility, versatility, and adaptability for protein profiling.


Ettan DIGE Imager features
• High sensitivity for imaging faint spots

• Software-selectable wavelengths

• Filter bandwidth optimized to minimize crosstalk

• Adjustable exposure level to optimize sensitivity

• Fast scanning for increased throughput

• Full 16 bits/pixel depth for accurate quantitation

• Sealed environment for scanning and protecting wet samples from drying

• Dedicated removable cassettes for handling and scanning gels—cassettes are available for naked gels or membranes and DALT and SE 600 series gel sandwiches

• Compatibility with Ettan Spot Picker

• Flat field calibration

• Compatible with image analysis software, such as ImageMaster, ImageQuant, or DeCyder software for quantitative evaluation of samples

• Two 1-GB/sec Ethernet connections for data transfer


Principle of operation
Upon excitation by the metal halide lamp, light is emitted from a fluorescently labeled sample in proportion to the amount of labeled compound in the sample. Emitted light is collected and converted to an electronic signal in a CCD. The signal is displayed and analyzed. Data is stored in a 16-bit Figure 3 compares color images of the same 2-D DIGE gel acquired on the Ettan DIGE Imager and the Typhoon™ scanner. For 2-D DIGE gels, the two instruments produce images of similar quality.


TIFF to provide the digital resolution required to characterize subtle signal intensity differences over the wide dynamic range of the instrument.

Figure 2 shows a typical gel image produced with the Ettan DIGE Imager.


Ordering information
Ettan DIGE Imager, including installation kit 63-0056-42
(power cable, CD with scan control
software, test slides, and user manual with
installation guidelines)

Ettan DIGE Imager Cassette, 276 x 212 mm, 11-0027-04
for DALT gel sandwiches

Ettan DIGE Imager Cassette, 180 x 160 mm, 11-0027-32
for SE 600 series gel sandwich es

Ettan DIGE Imager Cassette, with 11-0027-33
low-fluorescent glass, for naked gels


Imaging software
ImageMaster 2D Platinum v6.0 DIGE Enabled 11-0034-25

ImageMaster 2D Platinum v6.0 11-0034-27

DeCyder 2-D Differential Analysis 28-4012-01
Software v6.5, preinstalled network (including
PC and single concurrent network user license)

DeCyder 2-D Differential Analysis 11-0035-82
Software v6.5, one network user license

DeCyder Extended Data Analysis Software, 28-4012-03
one network user license

ImageQuant TL 63-0050-72



back to top
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS
2. 2D-LC analysis of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ
3. Multiplex protein detection with the ECL Plex fluorescent Western blotting system using the Ettan DIGE Imager
4. Sensitive identification of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):